A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults
Conditions: Severe Acute Respiratory Syndrome; Coronavirus; SARS-CoV-2; COVID-19 Interventions: Biological: CVnCoV Vaccine; Drug: Placebo Sponsors: CureVac AG; Coalition for Epidemic Preparedness Innovations (CEPI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials